AN OVERVIEW OF UNANCHORED INDIRECT TREATMENT COMPARISON METHODS IN NICE SINGLE TECHNOLOGY APPRAISALS
Author(s)
Matthew Knowles, MSc, MMath.
Astellas Pharma Europe Ltd, Addlestone, United Kingdom.
Astellas Pharma Europe Ltd, Addlestone, United Kingdom.
OBJECTIVES: By summarising the use of unanchored Indirect Treatment Comparisons (ITCs) used in Single Technology Appraisals (STAs) submitted to the National Institute for Health and Care Excellence (NICE). We were able to gain an understanding when unanchored comparisons are used, and what characteristics of these analyses made them successful.
METHODS: Data from each NICE appraisal were extracted from committee papers published between 1st January 2024 and 1st April 2026. Appraisals were excluded if they did not present any discussion of an ITC, were not STAs, or were terminated. Analysed studies used an unanchored comparison as the primary ITC method. The treatment, therapeutic area, presented pivotal study type, comparator data (for the ITC), and ITC method used were extracted from each STA, along with any comments made on the analysis.
RESULTS: Of 204 appraisals screened, 114 (55.88%) were excluded per the exclusion criteria. 28 appraisals were found to use an unanchored comparison as the base-case ITC. Only one TA used an unanchored Simulated Treatment Comparison (STC) as the primary ITC method, with 27 using unanchored Matching Adjusted Indirect Comparisons (MAICs).
CONCLUSIONS: Unanchored ITCs remain prevalent in NICE submissions. Indeed, unanchored MAIC was considerably more common than STC. This may be due to the current lack of a robust method for using STC with Time-To-Event outcomes.
METHODS: Data from each NICE appraisal were extracted from committee papers published between 1st January 2024 and 1st April 2026. Appraisals were excluded if they did not present any discussion of an ITC, were not STAs, or were terminated. Analysed studies used an unanchored comparison as the primary ITC method. The treatment, therapeutic area, presented pivotal study type, comparator data (for the ITC), and ITC method used were extracted from each STA, along with any comments made on the analysis.
RESULTS: Of 204 appraisals screened, 114 (55.88%) were excluded per the exclusion criteria. 28 appraisals were found to use an unanchored comparison as the base-case ITC. Only one TA used an unanchored Simulated Treatment Comparison (STC) as the primary ITC method, with 27 using unanchored Matching Adjusted Indirect Comparisons (MAICs).
CONCLUSIONS: Unanchored ITCs remain prevalent in NICE submissions. Indeed, unanchored MAIC was considerably more common than STC. This may be due to the current lack of a robust method for using STC with Time-To-Event outcomes.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
SA19
Topic
Economic Evaluation, Health Technology Assessment, Study Approaches
Topic Subcategory
Meta-Analysis & Indirect Comparisons
Disease
No Additional Disease & Conditions/Specialized Treatment Areas